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ABSTRACT
Protein misfolded oligomers are considered the most toxic species amongst those 
formed in the process of amyloid formation and the molecular basis of their toxicity, 
although not completely understood, is thought to originate from the interaction with 
the cellular membrane. Here, we sought to highlight the molecular determinants 
of oligomer-membrane interaction by atomic force microscopy. We monitored the 
interaction between multiphase supported lipid bilayers and two types of HypF-N 
oligomers displaying different structural features and cytotoxicities. By our approach 
we imaged with unprecedented resolution the ordered and disordered lipid phases 
of the bilayer and different oligomer structures interacting with either phase. We 
identified the oligomers and lipids responsible for toxicity and, more generally, we 
established the importance of the membrane lipid component in mediating oligomer 
toxicity. Our findings support the importance of GM1 ganglioside in mediating the 
oligomer-bilayer interaction and support a mechanism of oligomer cytotoxicity 
involving bilayer destabilization by globular oligomers within GM1-rich ordered raft 
regions rather than by annular oligomers in the surrounding disordered membrane 
domains.
INTRODUCTION
The aberrant self-assembly of peptide/protein 
molecules in the intra/extracellular space of tissues and 
organs to form highly structured fibrillar aggregates is 
associated with a group of highly debilitating pathological 
conditions including Alzheimer’s and Parkinson’s 
disease, familial amyloid polyneuropathy, spongiform 
encephalopathies, type II diabetes, systemic amyloidoses 
and many others [1-4]. In such diseases, particularly 
in neurodegenerative conditions, it is thought that an 
important cytotoxic role is played by small protein 
oligomers arising during peptide/protein aggregation. 
These toxic species form transiently during the process 
of aggregation as on- or off-pathways entities [5, 6], but 
can also be released from, or generated by, the fibrillar 
deposits that accumulate as end products in organs and 
tissues [7-9].
Studies on the N-terminal domain of the E. 
coli HypF protein (HypF-N) have contributed to our 
knowledge of the structural properties of these putatively 
pathogenic oligomers and of the mechanisms by which 
they cause toxicity to exposed cells [10-19]. Indeed, 
HypF-N is particularly useful to characterize the properties 
and the structure-toxicity relationship of misfolded 
oligomers for a number of reasons. First, HypF-N forms 
spherical oligomers and amyloid-like fibrils in vitro, under 
conditions that destabilize its native structure [14, 20-23]. 
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Second, HypF-N oligomers formed in vitro and added to 
the extracellular medium of cultured cells, [10-12, 14-17, 
19] or injected into rat brains [13, 15] impair cell viability 
similarly to oligomers found in many amyloid diseases. 
Third, HypF-N oligomers bind to cultured primary rat 
neurons and co-localise with post-synaptic densities, 
inhibit long-term potentiation (LTP) in rat hippocampal 
slices and induce cognitive impairment following their 
injection into rat brains, thus producing all the effects of 
the Aβ42 oligomers associated with Alzheimer’s disease 
at the biochemical, biological and electrophysiological 
levels [18]. Fourth, HypF-N can be purified to a high 
yield with relatively low costs and provides highly 
reproducible results in studies on protein aggregation and 
on the toxicity of the resulting oligomers [14, 15, 17, 24]. 
Fifth, HypFN is a bacterial protein not associated with 
amyloid diseases and for this reason provides general data 
that do not depend on possible modifications of specific 
cellular proteins undergoing aggregation. Finally, and very 
importantly, HypF-N oligomers are stable and maintain 
their morphological and structural properties even under 
conditions very different from those that promoted their 
formation, allowing their detailed study at the structural 
and biological level [14-16, 18, 19].
Two protocols have been established to form two 
different types of stable HypF-N oligomers, named type A 
(OA) and type B (OB), respectively [14]. These oligomeric 
forms share a similar size and morphology when observed 
by atomic force microscopy (AFM). In fact, both types 
are roughly spherical, with a diameter of 2-6 nm and 
bind thioflavin T (ThT) with similar enhancement of 
fluorescence, yet reduced with respect to that commonly 
observed for mature amyloid fibrils [14]. In spite of their 
common morphological and tinctorial properties, only 
OA display significant toxicity to cultured neuronal cells, 
cultured primary neurons and whole animal models [14-16, 
18]. In neuroblastoma cells, such a toxicity resulted from 
the interaction of the oligomers with the cell membrane 
with consequent Ca2+ influx from the extracellular space 
to the cytosol [15]. This early event triggers a complex 
cascade of effects, including an increase of intracellular 
ROS levels, cellular internalization of oligomers across the 
membrane, caspase-3 activation, mitochondrial sufferance, 
etc. resulting in cell death by apoptosis or necrosis [25] 
None of such effects was observed for OB, in spite of the 
observation that both OA and OB were able to physically 
interact with the cell membrane. This suggested that the 
very different biological effects of OA and OB could be 
the result of the different features of their initial interaction 
with the cell membrane [15]. 
ANS binding and site-directed pyrene labelling 
experiments led to propose that the different toxicity of OA 
and OB was attributable to the higher solvent-exposure 
and flexibility of hydrophobic amino acid residues located 
on the surface of the former with respect to the latter [14]. 
Later on, it was found that OA toxicity also depended 
on the lipid composition of the phospholipid bilayer. In 
particular, OA toxicity appeared to be modulated by the 
content of the ganglioside GM1, as its depletion from, 
or further addition to, neuroblastoma cells resulted in a 
dramatic loss or exacerbation of OA toxicity, respectively. 
Interestingly, cell enrichment with GM1 caused the 
normally non-toxic OB to become toxic, whereas cell 
depletion of GM1 caused the normally toxic OA to 
become non-toxic [16]. Overall, these results indicated that 
oligomer toxicity depends not only on specific structural 
properties of the oligomers themselves but also on the 
biochemical and biophysical properties of the membrane 
they interact with, in a delicate and complex interplay 
between the structural and physicochemical features of 
both [26]. Furthermore, these considerations add to, and 
confirm, previous and recent data indicating that GM1 
is a pivotal player in Aβ peptide neurotoxicity both by 
contributing to Aβ oligomer nucleation and growth into 
toxic fibrils [27, 28] and by sequestering Aβ oligomers 
from brain interstitial fluid onto neuronal membranes [29].
Since the interaction between HypF-N oligomers 
and the cell membrane is a central event of the resulting 
toxicity cascade, in the present study we sought to provide 
further information on this interaction. To this aim, we 
used both OA and OB and supported lipid bilayers (SLBs) 
that lacked, or contained a physiological content of GM1, 
and monitored the resulting interactions by AFM. By this 
approach we were able to isolate the contribution of the 
lipid component of the plasma membrane, separating it 
from that of the protein component in the evaluation of 
the oligomer-membrane interaction. It also allowed the 
imaging of such an interaction at the sub-microscopic 
level with high and unprecedented resolution and the 
discrimination between ordered and disordered lipid 
phases in the bilayer, which mimics the important 
distinction between lipid rafts and the surrounding 
disordered plasma membrane domains in natural cells.
RESULTS
Interaction between toxic and non-toxic HypF-N 
oligomers and lipid bilayers
HypF-N oligomers were preformed under two 
different conditions, traditionally referred to as condition A 
and condition B, as previously reported [14]. We will refer 
to the two types of oligomers as OA and OB, respectively. 
We formed separately model membranes as supported 
lipid bilayers (SLBs) composed of 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), sphingomyelin (SM), 
cholesterol (chol) with or without the ganglioside GM1 
(DOPC:SM:chol:GM1 and DOPC:SM:chol, respectively). 
Therefore, two different lipid mixtures, GM1-enriched or 
GM1-free, were used (+GM1 or −GM1, respectively). 
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SLBs prepared on mica from either lipid mixture 
displayed segregation of different lipid species in well 
distinct, differently ordered, domains. In particular, 
domains with low level of order, generally considered 
as fluid domains (L
α
 phase domains), were composed of 
DOPC. SM, chol and GM1 (when present) segregated 
in areas with a higher level of order, considered as gel 
phase domains (L
β 
phase domains) [30]. As expected, 
L
β
 and L
α
 domains also displayed different thickness; in 
particular, we consider ΔZ = Z
Lβ 
̶ Z
Lα 
, where Z
Lβ
 and Z
Lα
 
are the thickness of the ordered and disordered phases, 
respectively [30-32]. Since the Z
Lα
 was taken as our 
reference, it was given arbitrarily the value of 0 nm (Z
Lα
 
= 0 nm). Consequently, ΔZ = Z
Lβ
. Our analysis can be 
appreciated in the example shown in Figure 1A. A single 
line profile, corresponding to the white line indicated in 
Figure 1A, is shown in Figure 1B. An average value of ΔZ 
was calculated for each image considering the separation 
between the two peaks of the distribution of Z values fitted 
with the sum of two Gaussian curves (Figure 1C). 
ΔZ values for all the analysed conditions were 
obtained from the analysis of a variable number of images 
(n≥10). ΔZ was extremely reproducible, resulting in 
a value of 2.2±0.2 nm in the presence of GM1 (Figure 
2A). The administration of 12 μM OA to SLBs containing 
GM1 affected lipid organization, inducing a significant 
increase in ΔZ to a value of 3.7±0.4 nm (Figure 2B). The 
same behaviour was also observed on bilayers devoid of 
GM1. However, in this case the value of ΔZ was found 
to be 0.9±0.2 nm in the absence of protein oligomers 
(Figure 2D) and rose to 2.0±0.3 nm after oligomer 
administration (Figure 2E). A different scenario was 
found when lipid membranes were treated with non-toxic 
OB. In fact, in this case the ∆Z values measured after 
oligomer administration, 2.3±0.3 nm in the presence of 
GM1 (Figure 2C) and 1.0±0.4 nm in the absence of GM1 
(Figure 2F), were not significantly different from those 
measured in the absence of oligomers (Figure 2A, 2B). In 
Figure 1: Formation of L
α
 and L
β
 domains by segregation of lipid species in SLBs. A. Typical morphology of SLBs containing 
GM1 (DOPC:SM:chol:GM1). Scale bar: 1.0 µm. B. A cross section was taken along the white line in A (X axis). The difference in height 
between L
β
 and L
α
 is ≈ 2.2 nm. C. The height distribution of Z values, fitted with the sum of two Gaussian curves (green line), shows the 
difference in thickness (∆Z) between L
β
 and L
α
 domains.
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conclusion, only the addition of the toxic OA oligomers 
resulted in a remarkable increase of the difference in 
thickness between lipid phases of both GM1-enriched and 
GM1-free lipid membranes. 
An important insight in the mechanism of 
interaction of OA with SLBs was deduced from images 
acquired at higher lateral resolution. In the presence of 
GM1, OA interact, though differently, with both lipid 
phases (Figure 3A, 3B). In particular, an accumulation 
of globular aggregates, protruding by 2.0±0.5 nm from 
the membrane surface, was observed on the L
β
 phase of 
GM1-enriched lipid membranes (Figure 3A). Since the 
size of OA is 2-6 nm, as estimated in previous studies [14, 
17], we conclude that OA were partially inserted into the 
lipid membrane. By contrast, annular structures similar to 
those previously reported by several groups [33-35] were 
present in the L
α
 domains (Figure 3B). In the absence of 
GM1, the accumulation of OA on the L
β
 domains was 
not observed (Figure 3E), while the annular rings on the 
L
α
 domains were still visible (Figure 3F). This was not 
surprising considering that GM1 resides in the L
β
 domains 
and the L
α
 phase is not modified by the absence of GM1. 
Small oligomeric assemblies were not present on the SLBs 
surface after the administration of OB, as clearly shown 
in the images acquired at higher lateral resolution (Figure 
3C, 3D, 3G, 3H). In this case, both the L
β
 and L
α
 domains 
appeared essentially intact and did not display the presence 
of oligomers in the L
β
 phase (with the exception of rare 
large aggregates in GM1-enriched SLBs), or of annular 
structures in the L
α
 phase. The total distributions of height 
and width values of the globular and annular structures 
found in SLBs after exposure to HypF-N oligomers are 
shown in Figure 4. The corresponding mean values are 
summarized in Table I.
 The negatively charged sialic acid residue of GM1 
contributes to the interaction between HypF-N 
oligomers and lipid bilayers
We have previously reported that the sialic acid 
moiety of GM1 is essential for GM1-mediated toxicity of 
OA [16]. To better assess its role in the interaction between 
OA/OB oligomers and our supported lipid bilayers, 
GM1-enriched SLBs were treated with neuraminidase 
(NAA), which catalyses the removal of the sialic acid 
moiety from gangliosides (see Materials and methods for 
details). GM1-enriched SLBs presenting the two typically 
distinct lipid phases were observed in the absence of NAA 
treatment (Figure 5A). After treatment with NAA for 30 
min, the membrane structure was maintained, except for 
the presence of a few holes, due to the local removal of 
SLB patches following the multiple rinsing procedure 
(Figure 5B). Indeed, similar damages of SLBs were also 
Figure 2: SLBs imaging in the presence A.-C. or in the absence D.-F. of GM1. The images were acquired on bilayers that were 
left untreated A., D., treated with OA B., E. or treated with OB C., F., respectively. The height difference (∆Z) between L
β
 and L
α
 phases 
was estimated for each case by averaging the distance between Gaussian peaks in pixel height distributions associated with a variable 
number of images (n≥10). For both lipid mixtures, ΔZ increases after the administration of 12 µM OA B., E. and is preserved after the 
administration of the same concentration of OB C., F.. The colour bars correspond to a Z range of 8.0 nm. Scale bars: 1.0 µm.
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induced by consecutive rinsing steps in the absence of 
NAA. The height distribution after NAA treatment showed 
a slight decrease in ΔZ, from 2.2±0.2 nm, before NAA 
treatment, to 1.9±0.3 nm, after NAA treatment (Figure 5D, 
5E). 
ΔZ increased to 2.9±0.5 nm in NAA-treated SLBs 
exposed to OA (Figure 5C, 5F). In this case, aggregates 
mostly characterized by the annular shape were found on 
the L
α
 phase (Figure 5G), whereas no aggregates were 
observed on the L
β
 phase (Figure 5H). This scenario 
resembles that imaged in the absence of GM1 (Figure 3E, 
3F), suggesting that the sialic acid moiety is responsible 
for the differences observed between GM1-enriched and 
GM1-free membranes. 
Interaction between toxic and non-toxic HypF-N 
oligomers and neuronal cells
To assess whether our observations could be 
extended to a cellular system, we studied the interaction 
between HypF-N oligomers and human neuroblastoma 
SH-SY5Y cells. In particular, we performed a confocal 
microscopy analysis both on normal cells containing a 
physiological level of GM1, comparable to that of our 
SLBs containing GM1, and on cells treated with 25 µM 
D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-
propanol (PDMP), a glucosylceramide synthase inhibitor 
that reduces the GM1 content of the plasma membrane 
Figure 3: AFM images at higher lateral resolution. L
β
 and L
α
 phases of SLBs formed in the presence A.-D. or in the absence E.-H. 
of GM1 and after the administration of 12 µM OA A.,B.,E.,F. or OB C.,D.,G.,H.. Globular aggregates appear on the L
β
 phase only in the 
presence of GM1 and after administration of OA A. Annular aggregates appear on the L
α
 phase of both GM1-enriched and GM1-depleted 
SLBs after administration of OA B. and F.. OB interact scarcely with both L
α
 and L
β
 phases of both GM1-enriched and GM1-free SLBs 
C.,D.,G.,H.. Only a small number of large aggregates is observed on the L
β
 phase in the presence of GM1 C. The colour bars correspond 
to a Z range of 5.0 nm. Scale bars: 100 nm.
Table 1: Summary of the height and width values (means ± SD) of both globular oligomers and annular rings in both 
GM1-enriched and GM1-depleted SLBs.
+GM1 −GM1
Globular oligomers Annular rings Globular oligomers Annular rings
height (nm) 2.0±0.5 0.4±0.2 - 0.4±0.2
width (nm) 34±8 19±4 - 19±4
The width values were measured as the widths at half height for globular oligomers and as peak to peak distances for annular 
rings.
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by blocking its biosynthesis [36]. Both basal and 
PDMP-treated cells were exposed to 12 µM (monomer 
equivalent) OA or OB and the degree of co-localization 
of the oligomers (green channel) with the cell membrane 
(red channel) was assessed by measuring the Pearson 
correlation coefficient (PCC) (Figure 6). The images were 
scanned at apical planes to detect oligomers interacting 
with the cell surface rather than internalized inside 
the cells. A large number of OA bound to the plasma 
membrane was found in OA-exposed cells with basal 
GM1 content (Figure 6B), whereas the same oligomers 
were undetectable in PDMP-treated cells incubated with 
Figure 4: A. The width (w) of globular oligomers in the L
β
 phase was measured at half height of the aggregates, while the width (w) 
of annular rings in the L
α
 phase represents the diameter of the circular structure, calculated as shown in the figure. The height (h) of both 
aggregates was determined as the difference of height between the L
α
 or L
β
 phase and the top of the aggregates. B.-G. Distributions of h 
B.,C.,D. and w E.,F.,G. values for globular B.,E. and annular C.,D.,F.,G. structures calculated on GM1-enriched B.,C.,E.,F. and GM1-
depleted D.,G. SLBs.
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OA (Figure 6E). By contrast, cells containing basal GM1 
levels exposed to OB recruited a small number of large 
aggregates (Figure 6C) and the PDMP-treated cells did not 
bind oligomers (Figure 6F).
DISCUSSION
A great deal of experimental evidence indicates that 
the interplay between oligomers arising from misfolded 
proteins/peptides and lipid membranes has a primary 
role in defining the cytotoxicity cascade associated with 
protein aggregation [5, 26, 37, 38]. It has also been 
reported that anionic lipids in the cell membranes promote 
the aggregation process of amyloidogenic peptides [39-
42]. At the same time, other studies indicate that the 
toxicity of protein misfolded oligomers is directly related 
to their ability to affect the physiological functions of the 
cell membrane [33, 43-46]. In particular, in the last few 
years, great interest has been focused on the role of the 
negatively charged GM1 molecule, both as a nucleator 
of peptide/protein aggregation, as a key interaction site 
of pre-formed oligomers, and as a determinant of protein 
oligomer toxicity [16, 27-29, 47-51]. An interesting 
exemplification of the intimate interplay between oligomer 
Figure 5: A., B., C. SLBs containing 5.0% GM1 before A.and after B., C. treatment with NAA, and before A., B. and after C. administration 
of 12 µM OA. The colour bars correspond to a Z range of 8.0 nm. Scale bars: 1.0 µm. D.,E.,F. Height distributions taken from the images 
shown in panels A, B and C, respectively, fitted to the sum of two Gaussian functions (green lines). G., H. Magnification of the rectangular 
areas marked in panel C. After removal of the negatively charged sialic acid, protein aggregates are present in the L
α
 domain G., but not in 
L
β
 domains H.. The colour bars correspond to a Z range of 5.0 nm. Scale bars: 100 nm.
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structure and cell membrane composition is offered by 
the behaviour of the amyloid-forming protein domain 
HypF-N. It has been shown that the toxicity of HypF-N 
oligomers depends on both the oligomer structure and 
the physicochemical properties of the lipid membrane 
arising from its lipid composition [14, 16, 17, 19]. Only 
the oligomeric form here called OA appeared to be toxic 
to cultured neuronal cells, cultured primary neurons and 
whole animal models, resembling the effects of toxic Aβ 
oligomers, while the oligomeric form here called OB was 
not found to significantly affect cell viability and animal 
cognitive abilities [14-16, 18]. The toxicity of OA could be 
reduced or enhanced by depleting or increasing the content 
of membrane GM1 in neuroblastoma cells, respectively, 
whereas the non-toxic OB became toxic to GM1-enriched 
cells [16]. These data strongly suggested that GM1 is 
a main mediator of oligomer toxicity and agreed with 
similar data obtained with two types (toxic and non-toxic) 
of Aβ oligomers leading to propose a generalisation of 
these conclusions [16].
Since the interaction between HypF-N oligomers 
and the cell membrane is a central event of oligomer-
induced cytotoxicity, we initially used SLBs as a model 
system to mimic the interaction between cell membranes 
Figure 6: Representative confocal scanning microscopy images of the apical sections of neuroblastoma SH-SY5Y cells 
with basal A., B., C. or reduced D., E., F. GM1 content. The images were acquired on untreated A., D., OA-treated B., E. or OB-
treated C., F. cells, respectively. The cells were exposed for 1.0 h to OA or OB (12 µM, monomer equivalent concentration). Red and green 
fluorescence indicates the cell membranes and the oligomers, respectively. The cytofluorograms of the three apical sections associated 
with the various images show the green versus red fluorescence intensity (as pixel intensity). The histograms show the percentage of 
co-localisation on regions of interest (12-13 cells) using the ImageJ (NIH, Bethesda, MD, USA) and JACOP plugin (rsb.info.nih.gov) 
software. Data are expressed as mean ± S.D. (n = 4 per group). Double asterisk: p ≤ 0.01 with respect to cells with basal GM1 content. 
Scale bars: 15.0 µm.
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and HypF-N oligomers. All the variables playing some 
role in this interaction were considered by studying the 
behaviour of the two isoforms, OA and OB, and using 
GM1-free SLBs, or SLBs containing a GM1 concentration 
similar to that found in the plasma membrane of neuronal 
cells. This approach allowed the contribution of the lipid 
component of the plasma membrane to be evaluated 
independently of that of the proteins populating the 
membrane itself and the oligomer-membrane interaction 
to be monitored with unprecedented resolution. In fact, 
we imaged the morphology of the oligomers and their 
mode of interaction with the membrane; at the same time 
it was possible to discriminate between the ordered and 
disordered lipid phases of the bilayer, recalling some 
features found in the lipid rafts and in the surrounding 
membrane bilayer in cells, respectively. The results 
obtained by the AFM analysis were compared with those 
derived by confocal microscopy of cell membranes to 
parallel the data obtained with the first approach with 
those obtained with cultured cells.
The main findings of the present study can be 
summarized in the following four points. The first 
important observation is that OA and OB interact very 
differently with SLBs; in particular, OA display greater 
affinity to the lipid membrane, confirming the data 
obtained here and previously with neuroblastoma cells 
[16]. The high resolution images show that OA bound 
more extensively and deeply than OB to the lipid bilayer 
(Figure 3A-3D). Moreover, the interaction between OA 
(but not OB) and SLBs was found to induce structural 
changes of the overall bilayer structure, with a significant 
increase in ∆Z (Figure 2). This effect cannot be due to an 
increase in thickness of the L
β 
phase domains, in which 
the lipid chains are already stretched. Furthermore, higher 
magnification images excluded that one or more layers of 
oligomers were formed on the top of these regions. The 
formation of multilayer domains was also excluded by a 
topographical analysis; in fact, the average value of ∆Z 
was increased by 1.5 nm in the presence of GM1 and by 
1.1 nm in its absence, which is an insufficient increase to 
justify the formation of a second lipid bilayer. All these 
considerations lead us to conclude that the observed 
variation of ∆Z results from some decrease in thickness 
of the L
α
 phase domains, likely due to the promotion of a 
thinner, possibly interdigitated, phase, in agreement with 
previous findings obtained on single phase SLBs [52, 53]. 
A second important observation is that OA interact 
with both the L
α
 and L
β
 phase domains of the membrane 
with two different morphologies (Figure 3A, 3B). 
However, GM1 mediates the interaction only with the 
L
β
 phase domain as GM1 resides only in this phase and 
its absence in GM1-free SLBs causes the loss of the OA-
L
β
 interaction while maintaining the OA-L
α
 association 
(Figure 3E and 3F). Experiments performed on GM1-
enriched SLBs treated with NAA showed that this 
interaction is also suppressed by removing the sialic acid 
residue of GM1, clearly indicating that the high affinity 
between OA and GM1-enriched L
β 
phase domains is 
driven mainly by the sialic acid moiety, possibly through 
electrostatic interactions (Figure 5).
A third finding is that only the oligomers interacting 
with the L
β
 phase domain of the SLBs appear to be 
responsible for cytotoxicity since their amount correlates 
with that of the oligomers bound to the membrane of 
neuroblastoma cells and the ensuing cytotoxicity [16]. 
Indeed, the level of interaction found here followed the 
ranking OA-L
β
 > OB-L
β
 > OA/OB-L
β
 in GM1-free SLBs, 
which parallels that found in neuroblastoma cells: OA-
cell > OB-cell > OA/OB-cell in GM1-depleted cells. 
Such a ranking matched that of the observed toxicity: OA 
cytotoxicity > OB cytotoxicity > OA/OB cytotoxicity to 
GM1-depleted cells [16]. Interestingly, OA are no longer 
toxic to GM1-depleted cells and this parallels our finding 
in GM1-free SLBs, where only the OA-L
β
 interaction was 
lost, whereas the interaction with the L
α
 phase domain was 
maintained. In other words, a parallel does exist between 
(i) HypF-N oligomers bound to the L
β
 phase domain of 
SLBs, (ii) HypF-N oligomers bound to the cell membrane 
and (iii) oligomer cytotoxicity.
A fourth important finding emerging from our 
study is that no correlation appears to exist between 
OA that adopt a pore-like morphology upon binding to 
the L
α
 phase domain of the SLBs and any cytotoxicity. 
Indeed, OA bound to the L
α
 phase domain both in GM1-
enriched and in GM1-depleted SLBs (Figure 3B, 3F), 
whereas their cytotoxicity was dramatically reduced 
only in GM1-depleted cells [16]. Moreover, a large 
distribution of OA was clearly detected in oligomer-
exposed SH-SY5Y cells with basal GM1 content and the 
high level of co-localization indicated that the aggregates 
were present at the cell membrane level (Figure 6B). By 
contrast, OA displayed little affinity for PDMP-treated 
(GM1-depleted) cells (Figure 6E). Hence, the GM1-
independent affinity of OA for the L
α
 phase domain of 
SLBs resulting in the insertion of annular structures in 
the lipid bilayer, is strongly reduced, if not completely 
missing, at the cell membrane level. This finding rules out 
that the cytotoxicity of OA is entrusted with the ability of 
these species to adopt a pore-like morphology in the cell 
membrane; rather it indicates that the spherical or disc-
shaped oligomers bound to the L
β
 phase domain are the 
true toxic species. 
The tendency of protein oligomers to interact 
with synthetic lipid membranes supports the idea that 
the interaction is not driven by the action of specific 
membrane protein targets but, possibly, is modulated by 
electrostatic interactions between the negatively charged 
GM1 molecules and the positive charge distribution 
within HypF-N oligomers and between the hydrophobic 
environment of the bilayer interior and by the hydrophobic 
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groups on the surface of the protein oligomers. However, 
the possibility that intracellular calcium overload can 
in part be due to the interaction of oligomers with 
endogenous calcium-permeable channels or membrane 
receptors cannot be ruled out. In this context, several 
cell surface proteins have been considered as possible 
candidate receptors of Aβ oligomers, including APP 
[54], tumor-necrosis factor receptor-1 (TNFR1) [55], the 
receptor for advanced glycation end products (RAGE) 
[56], the non-infectious form of the prion protein (PrPc) 
[57], voltage-gated calcium channels [58] or ligand-
gated calcium channels such as the glutamate N-methyl 
D-aspartate (NMDA) receptors and the α-amino-3-
hydroxy-5-methyl- 4-isoxazolepropionic acid (AMPA) 
receptor [59, 60].
In conclusion, our findings, together with the 
toxicity data obtained with cultured cells [16], indicate 
that the importance of GM1 in mediating the cytotoxicity 
of HypF-N oligomers can be traced back to its ability 
to recruit protein aggregates to lipid raft domains of the 
cell membrane, a behaviour that appears mainly due to 
the negative charge of GM1 and does not require the 
participation of specific or generic protein components 
or the adoption of a well defined annular morphology by 
the oligomers. These data add to, and complement, those 
previously reported showing the key importance of GM1 
and its clusters in the neuronal membrane not only as 
promoters of Aβ aggregation [27, 28], but also as binders 
of Aβ oligomers [29, 61], In the past years, the observation 
of annular amyloid structures on model membranes, as 
well as of an increased membrane permeability to Ca2+ 
ions in aggregate-exposed synthetic bilayers and cultured 
cells, led to the formulation of the “channel hypothesis”. 
This states that the altered intracellular calcium 
concentration in cells treated with protein misfolded 
oligomers is related to uncontrolled calcium fluxes 
resulting from the organization of non-specific pores 
in aggregate-exposed bilayers [34, 62-64]. In contrast 
with this view, and in agreement with another part of 
literature [43], our study indicates that the cytotoxicity of 
protein misfolded oligomers is related to a more general 
mechanism involving the destabilization and disassembly 
of the lipid membrane within the lipid raft regions, 
causing an influx of Ca2+ ions from the extracellular to the 
intracellular environment.
MATERIALS AND METHODS
Synthetic lipid vesicle preparation and SLBs 
formation
1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC,18:1), sphingomyelin (SM) (brain, porcine) 
and ganglioside GM1 (brain, ovine - sodium salt) were 
purchased from Avanti Polar Lipids (Alabaster, AL, 
USA). Cholesterol (Chol), chloroform and methanol were 
from Sigma-Aldrich (St Louis, MO, USA). Two different 
lipid mixtures were used for vesicle preparation, the first 
composed of DOPC/SM 2:1 (mol/mol) + 1.0% (mol) 
cholesterol and the second composed of DOPC/SM 2:1 
(mol/mol) + 1.0% (mol) cholesterol + 5.0% (mol) GM1 
(DOPC:SM:chol and DOPC:SM:chol:GM1, respectively). 
The phospholipid powder was dissolved in chloroform/
methanol (2:1), according to the desired composition, and 
gently evaporated to dryness under nitrogen flux. Aliquots 
of the mixture were stored overnight under vacuum and 
resuspended in Milli-Q water at a lipid concentration of 
0.5 mg/mL to form multilamellar vesicles (MLVs). MLVs 
suspensions were let to swell for 1.0 h at 60 °C and then 
extruded 11 times through a polycarbonate membrane with 
100 nm pores using a commercial extruder (Avanti Polar 
Lipids) at the same temperature, to form large unilamellar 
vesicles (LUVs). After cooling at room temperature, 
LUVs suspension was diluted 5 fold with Milli-Q water. 
Then, 40 µL of each suspension and 10 µL of a 10 mM 
CaCl2 solution were deposited onto a 1.0 cm × 1.0 cm 
freshly cleaved mica substrate. In order to get uniform 
bilayer coverage, the samples were stored 10 min at room 
temperature and then incubated 15 min at 60 °C in a close 
chamber with 100% relative humidity. The samples were 
cooled at room temperature and, after 2.0 h, gently rinsed 
three times with Milli-Q water to remove excess vesicles 
from the liquid subphase before AFM measurements.
Sialic acid removal
The removal of the sialic acid residues from 
DOPC:SM:chol:GM1 bilayers was achieved by treating 
the lipid bilayer with a neuraminidase (NAA) cocktail 
(117 mU/mL of Vibrio cholerae NAA and 33 mU/mL 
of Arthrobacter ureafaciens NAA, both purchased from 
Sigma-Aldrich) for 30 min at room temperature. The 
sample was rinsed three times with Milli-Q water before 
AFM imaging.
Preparation of HypF-N oligomers
HypF-N was purified as previously described [14]. 
HypF-N oligomers were prepared, starting from frozen 
aliquots of the purified native protein, using two different 
aggregation conditions, as previously described [14]. In 
brief, for toxic OA preparation, stock aliquots of native 
HypF-N were diluted to 0.5 mg/ml in 50 mM acetate 
buffer containing 12% (v/v) trifluoroethanol (TFE), 2.0 
mM dithiothreitol, at pH 5.5. After 4.0 h incubation at 
25 °C, the solution was centrifuged at 16,100 r.c.f. for 10 
min and resuspended in PBS at 0.5 mg/mL concentration 
. Non-toxic OB were prepared by the same procedure, but 
using 20 mM trifluoroacetic acid (TFA), 330 mM NaCl, 
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pH 1.7 as aggregation buffer. 
AFM imaging
AFM images were acquired by using a Nanowizard 
III (JPK Instruments, Germany) mounted on an Axio 
Observer D1 (Carl Zeiss, Germany) inverted optical 
microscope. V-shaped DNP silicon nitride cantilevers 
(Bruker, MA, USA), with a nominal spring constant 0.24 
N/m, resonance frequency in air ranging from 40 kHz 
to 75 kHz and tip typical curvature radius of 20-60 nm 
were used. Intermittent contact mode AFM images were 
acquired in the constant-amplitude mode, working in 
water with an oscillating frequency of 10-20 kHz. The 
amplitude setpoint was kept above 70% of free oscillation 
amplitude in all cases. OA and OB were administered to 
the sample under the AFM head at a final concentration 
of 12 µM and left standing for 30 min. The difference in 
thickness between ordered (L
β
) and disordered (Lalpha) 
lipid domains (ΔZ) was determined by considering image 
height distributions: the values of height per each one of 
the 512×512 image data points were calculated by using 
the JPK Data Processing software (JPK Instruments, 
Germany). Raw data were plotted by using Origin 
(OriginLab, MA, USA) and the distributions were fitted 
to the sum of two Gaussian functions. The ΔZ value 
associated with each image was the separation between 
the peaks of the two Gaussian curves. This procedure 
was repeated for at least 10 different images for each 
experiment.
Oligomer binding to the cell membrane
Human neuroblastoma SH-SY5Y cells (A.T.C.C. 
Manassas, VA, USA) were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM), F-12 Ham with 
25 mM HEPES and NaHCO3 (1:1) supplemented with 
10% fetal bovine serum (FBS), 1.0 mM glutamine and 
1.0% penicillin and streptomycin solution in a 5.0% CO2 
humidified atmosphere at 37 °C. The cells were seeded on 
glass coverslips and cultured with the cell culture medium 
described above (basal GM1 content) or supplemented 
with 25 µM D-threo-1-phenyl-2-decanoylamino-3-
morpholino-1-propanol (PDMP) for 48 h at 37 °C (low 
GM1 content). Then the cells were treated for 1.0 h 
with 12 μM (monomer equivalent) OA or OB and, after 
incubation, counterstained with 5.0 μg/mL Alexa Fluor 
633-conjugated wheat germ agglutinin. The presence 
of oligomers was detected with 1:1000 diluted rabbit 
polyclonal anti-HypF-N antibodies and subsequently 
with 1:1000 diluted Alexa Fluor 488-conjugated anti-
rabbit secondary antibodies. Fluorescence emission was 
detected after double excitation at 488 nm and 633 nm by 
a TCS SP5 scanning confocal microscopy system (Leica 
Microsystems, Mannheim, Germany) equipped with 
an argon laser source. A series of 1.0 µm thick optical 
sections (1024 × 1024 pixels) was taken through the 
cell depth for each sample using a Leica Plan Apo 63× 
oil immersion objective and three apical sections were 
projected as a single composite image by superimposition. 
Oligomer and apical cell membrane co-localisation was 
estimated for regions of interest in 12-13 cells, in four 
different experiments, using ImageJ and JACOP plugin 
(http://www.rsb.info.nih.gov) software and expressed as 
fraction of oligomer binding by the Pearson’s correlation 
coefficient (PCC).
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